Professor Christopher Layton

Professor Layton is a clinical ophthalmologist and national leader in innovative ophthalmology with expertise in macular disease, lens surgery and minimally invasive glaucoma interventions.  He was educated in Brisbane at Villanova College, completed ophthalmology training in Queensland, Oxford and London, subspecialty training in retinal disease at the Royal Brisbane Hospital and holds a PhD in diabetic retinopathy from Oxford University.  He is a Rhodes Scholar, director of the LVF Ophthalmology Research Centre in Brisbane, Australia, and founder of Ocugene, a Queensland based biotechnology start-up which is commercialising his gene therapy discoveries to cure macular degeneration, eye inflammation and eye cancer.   Professor Layton’s work has been widely published in the international literature and has been recognised by multiple international awards. 

Cataract and Lens surgery, Macular Disease, Glaucoma, Diabetic Retinopathy, Dry Eye.